15:34:18 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-09-10 Årsstämma 2025
2024-06-05 Bokslutskommuniké 2024
2024-03-08 Kvartalsrapport 2024-Q3
2023-12-15 Kvartalsrapport 2024-Q2
2023-10-09 Inlösen SECT B 1.1
2023-09-08 Ordinarie utdelning SECT B 0.00 SEK
2023-09-07 Årsstämma 2024
2023-09-05 Kvartalsrapport 2024-Q1
2023-06-02 Bokslutskommuniké 2023
2023-03-10 Kvartalsrapport 2023-Q3
2022-12-16 Kvartalsrapport 2023-Q2
2022-10-10 Inlösen SECT B 1
2022-09-09 Ordinarie utdelning SECT B 0.00 SEK
2022-09-08 Årsstämma 2023
2022-09-02 Kvartalsrapport 2023-Q1
2022-06-03 Bokslutskommuniké 2022
2022-03-09 Kvartalsrapport 2022-Q3
2021-12-10 Kvartalsrapport 2022-Q2
2021-10-18 Inlösen SECT B 0.9
2021-09-24 Split SECT B 1:5
2021-09-15 Ordinarie utdelning SECT B 0.00 SEK
2021-09-14 Årsstämma 2022
2021-09-03 Kvartalsrapport 2022-Q1
2021-06-02 Bokslutskommuniké 2021
2021-03-12 Kvartalsrapport 2021-Q3
2020-11-27 Kvartalsrapport 2021-Q2
2020-10-05 Inlösen SECT B 4.5
2020-09-09 Ordinarie utdelning SECT B 0.00 SEK
2020-09-08 Årsstämma 2021
2020-09-04 Kvartalsrapport 2021-Q1
2020-06-03 Bokslutskommuniké 2020
2020-03-04 Kvartalsrapport 2020-Q3
2019-11-28 Kvartalsrapport 2020-Q2
2019-10-02 Inlösen SECT B 4.5
2019-09-06 Ordinarie utdelning SECT B 0.00 SEK
2019-09-05 Årsstämma 2020
2019-09-03 Kvartalsrapport 2020-Q1
2019-05-28 Bokslutskommuniké 2019
2019-03-06 Kvartalsrapport 2019-Q3
2018-12-07 Kvartalsrapport 2019-Q2
2018-10-03 Inlösen SECT B 4.5
2018-09-07 Ordinarie utdelning SECT B 0.00 SEK
2018-09-06 Årsstämma 2019
2018-09-04 Kvartalsrapport 2019-Q1
2018-05-29 Bokslutskommuniké 2018
2018-03-12 Kvartalsrapport 2018-Q3
2017-12-08 Kvartalsrapport 2018-Q2
2017-10-02 Inlösen SECT B 4.5
2017-09-14 Ordinarie utdelning SECT B 0.00 SEK
2017-09-13 Årsstämma 2018
2017-09-12 Kvartalsrapport 2018-Q1
2017-05-30 Bokslutskommuniké 2017
2017-03-07 Kvartalsrapport 2017-Q3
2016-12-07 Kvartalsrapport 2017-Q2
2016-10-04 Inlösen SECT B 4.5
2016-09-07 Ordinarie utdelning SECT B 0.00 SEK
2016-09-06 Årsstämma 2017
2016-09-05 Kvartalsrapport 2017-Q1
2016-05-31 Bokslutskommuniké 2016
2016-03-08 Kvartalsrapport 2016-Q3
2015-12-08 Kvartalsrapport 2016-Q2
2015-09-28 Inlösen SECT B 4.5
2015-09-15 Kapitalmarknadsdag 2015
2015-09-08 Ordinarie utdelning SECT B 0.00 SEK
2015-09-07 Årsstämma 2016
2015-09-07 Kvartalsrapport 2016-Q1
2015-06-03 Bokslutskommuniké 2015
2015-03-10 Kvartalsrapport 2015-Q3
2014-12-09 Kvartalsrapport 2015-Q2
2014-09-25 Inlösen SECT B 4.5
2014-09-09 Ordinarie utdelning SECT B 0.00 SEK
2014-09-08 Årsstämma 2015
2014-09-08 Kvartalsrapport 2015-Q1
2014-05-27 Bokslutskommuniké 2014
2014-03-04 Kvartalsrapport 2014-Q3
2013-12-10 Kvartalsrapport 2014-Q2
2013-09-10 Kvartalsrapport 2014-Q1
2013-07-11 Inlösen SECT B 4.5
2013-06-28 Ordinarie utdelning SECT B 0.00 SEK
2013-06-27 Årsstämma 2013
2013-05-29 Bokslutskommuniké 2013
2013-05-28 Bokslutskommuniké 2012
2013-05-28 Analytiker möte 2013
2013-03-06 Kapitalmarknadsdag 2013
2013-03-05 Kvartalsrapport 2012-Q3
2012-12-04 Kvartalsrapport 2012-Q2
2012-09-04 Kvartalsrapport 2012-Q1
2012-07-12 Inlösen SECT B 5
2012-06-29 Ordinarie utdelning SECT B 0.00 SEK
2012-06-28 Årsstämma 2011
2012-05-22 Analytiker möte 2011
2012-05-21 Bokslutskommuniké 2011
2012-03-05 Kvartalsrapport 2011-Q3
2011-12-06 15-7 2011
2011-12-05 Inlösen SECT B 5
2011-12-04 Kvartalsrapport 2011-Q2
2011-11-23 Ordinarie utdelning SECT B 0.00 SEK
2011-11-22 Extra Bolagsstämma 2011
2011-09-04 Kvartalsrapport 2011-Q1
2011-05-24 Bokslutskommuniké 2010
2011-03-08 Kvartalsrapport 2010-Q3
2010-07-01 Ordinarie utdelning SECT B 0.00 SEK
2010-06-30 Årsstämma 2010
2010-05-25 Bokslutskommuniké 2009
2010-03-16 Kvartalsrapport 2009-Q3
2009-12-08 Kvartalsrapport 2009-Q2
2009-09-14 Kvartalsrapport 2009-Q1
2009-06-29 Ordinarie utdelning SECT B 0.00 SEK
2009-06-26 Årsstämma 1
2008-06-26 Ordinarie utdelning SECT B 0.50 SEK
2007-06-29 Ordinarie utdelning SECT B 0.50 SEK
2006-06-29 Ordinarie utdelning SECT B 0.50 SEK
2000-08-11 Split SECT B 1:3

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Sectra är verksamt inom säkerhetslösningar. Störst affärsinriktning återfinns inom medicinteknik och cybersäkerhet. Bolaget utvecklar IT-lösningar som används bland sjukhus, institut och myndigheter på global nivå för hantering av kritisk infrastruktur samt känslig datainformation. Störst verksamhet återfinns inom den europeiska marknaden, där lösningarna säljs via flertalet dotterbolag. Sectra grundades 1978 och har sitt huvudkontor i Linköping.
2021-08-12 08:35:00

Linköping, Sweden and Almere, the Netherlands - August 12, 2021 - University Medical Center (UMC) Utrecht in the Netherlands has signed a 10-year renewal contract for digital pathology with international medical imaging IT and cybersecurity company Sectra (http://www.sectra.com/) (STO: SECT B). In 2016, UMC Utrecht was among the first in the world to start digitally reviewing tissue sections for primary diagnostics and the renewal represents a continued joint commitment to driving innovation within digital pathology for the benefit of patients.

"UMC Utrecht has always had the ambition to be in the forefront of improving patient care by digitizing pathology. The ease-of-use of the Sectra solution combined with its vendor neutrality with regards to scanners, LIS, EMR and AI applications has helped us achieve tangible positive outcomes. We now look forward to working together with Sectra to continue to improve how technology facilitates the daily work for our pathologists and their patients," says Prof. Paul van Diest, head of the Pathology Department at UMC Utrecht.

The contract was signed in July 2021. UMC Utrecht has used Sectra's pathology module since 2016 and the radiology module since 2011. Pathologists and radiologists have joint access to radiology and pathology images, enabling more effective multidisciplinary discussions. 

UMC Utrecht digitized pathology early and was thus among the first to connect the solution to the nationwide telepathology project, PIE. It enabled them to carry out consultations and revisions digitally with other connected pathology laboratories in the Netherlands as well as participate in digital expert panels. During this year's pandemic, Sectra's solution has also enabled the pathologists to continue their important work from home. 

"Vendor neutrality, workflow support, integrations and the ability to scale are key for reaping the full benefits of digital pathology. Sectra has proven to be a future-proof vendor with a solid focus on customer satisfaction," says Tri Nguyen, Pathologist at UMC Utrecht.

The pathology department at UMC Utrecht employs about 20 pathologists and 15 residents, and handles more than 40,000 requests per year. They are 100% digital. 

"We are thrilled to continue our relationships with UMC Utrecht. They are in the forefront of patient care in many aspects, and their continued trust in us and our solutions is a testament of our position within digital pathology," says Peter Osinga, Managing Director of Sectra in the Netherlands.

Sectra's enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra's website to read more about Sectra and why its digital pathology solution is ranked 'Best in KLAS (https://medical.sectra.com/about-sectra/sectra-pacs-best-in-klas/)'.

About Sectra
Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website (https://sectra.com/).